These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12705093)

  • 1. Lithium carbonate 24-hour extended-release capsule filled with 6 mm tablets.
    Pietkiewicz P; Sznitowska M; Dorosz A; Lukasiak J
    Boll Chim Farm; 2003; 142(2):69-71. PubMed ID: 12705093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization.
    Patel V; Chudasama A; Nivsarkar M; Vasu K; Shishoo C
    Pharm Dev Technol; 2012; 17(3):375-82. PubMed ID: 21284541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose bioavailability of two extended-release lithium carbonate products.
    Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
    Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets].
    Toskić-Radojcić M; Pavlović M; Gazikalović E; Arandjelović A; Kovacević A
    Vojnosanit Pregl; 2012 Aug; 69(8):675-80. PubMed ID: 22924263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computerised sampling strategy for therapeutic drug monitoring of lithium provides precise estimates and significantly reduces dose-finding time.
    Hoegberg LC; Jürgens G; Zederkof VW; Holgersson B; Andersson JE; Dalhoff KP; Larsen EB; Angelo HR
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):259-63. PubMed ID: 21933347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Manufacture of lithium carbonate tablets using direct compression].
    Gazikolović E; Obrenović D; Nidzović Z
    Vojnosanit Pregl; 1999; 56(4):389-92. PubMed ID: 10528525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.
    Dashevsky A; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of hemodialysis in the management of acute lithium intoxication].
    Maghraoui JE; Kabbali N; Arrayhani M; Houssaini TS
    Pan Afr Med J; 2016; 24():27. PubMed ID: 27583091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower serum levels of lithium may produce efficacy without adverse effects.
    Shim SS
    Am J Geriatr Psychiatry; 2009 Jul; 17(7):625; author reply 625-6. PubMed ID: 19546659
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lithium carbonate].
    Higuchi S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():385-7. PubMed ID: 15658344
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
    Ciftçi K; Capan Y; Oztürk O; Hincal AA
    Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology.
    Ando M; Kojima S; Ozeki Y; Nakayama Y; Nabeshima T
    Int J Pharm; 2007 May; 336(1):99-107. PubMed ID: 17223295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of three different diets on the bioavailability of a sustained release lithium carbonate matrix tablet.
    Gai MN; Thielemann AM; Arancibia A
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):320-6. PubMed ID: 10890582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian company recalls bipolar disorder drug.
    FDA Consum; 2005; 39(2):4. PubMed ID: 16124080
    [No Abstract]   [Full Text] [Related]  

  • 19. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder.
    Mintz M; Hollenberg E
    Psychopharmacol Bull; 2019 Jun; 49(2):28-40. PubMed ID: 31308580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.